Nexthera Capital’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Nexthera Capital’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-654,532	Closed	-$11.6M	–	58
2018 Q3	$11.6M	Buy	654,532 +58,532	+10%	+$1M	2.23%	12
2018 Q2	$8.22M	Buy	+596,000	New	+$7.07M	1.27%	25

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Nexthera Capital's ECYT Position: Q4 2018 in Review

Nexthera Capital sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 654,532 shares — an estimated $11.6M sold.

Nexthera Capital first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $11.6M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Nexthera Capital reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Nexthera Capital sold 654,532 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $11.6M.
Nexthera Capital first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Nexthera Capital's Endocyte, Inc. Common Stock position peaked at $11.6M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.